Peripheral level of CD33 and Alzheimer’s disease: a bidirectional two-sample Mendelian randomization study

Increased expression of CD33 in the brain has been suggested to be associated with increased amyloid plaque burden, while the peripheral level of CD33 in Alzheimer’s disease (AD) patients and its role in AD remain unclear. The current study aimed to systematically explore the bidirectional relations...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Xiaojing, Dou, Meng, Cao, Bei, Jiang, Zheng, Chen, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529877/
https://www.ncbi.nlm.nih.gov/pubmed/36192375
http://dx.doi.org/10.1038/s41398-022-02205-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529877/
https://www.ncbi.nlm.nih.gov/pubmed/36192375
http://dx.doi.org/10.1038/s41398-022-02205-4

Ejemplares similares